Literature DB >> 12531119

Systemic hypertension and obstructive sleep apnoea.

Justin C T Pepperell1, Robert J O Davies, John R Stradling.   

Abstract

This article is a review of the current evidence that links systemic hypertension with obstructive sleep apnoea. Whilst a causal association has been suspected for some time, the day to day variability of both blood pressure and sleep apnoea severity, and clustering of confounding cardiovascular risk factors in sleep apnoea patients has made this association difficult to prove. There is unassailable evidence that obstructive apnoeas raise blood pressure acutely in both animal models and humans, through a combination of autonomic and state dependent arousal with some mechanical influences, and these rises can be controlled by nasal continuous positive airway pressure. Thus, although repetitive apnoeas alter the blood pressure variability and raise sleeping blood pressure in patients with OSA and sophisticated animal models have demonstrated increases in daytime blood pressure after the onset of OSA in the short term, such effects on diurnal BP have yet to be proven in humans. Recent rigorously designed large epidemiological studies have proven an independent association between OSA and systemic hypertension in both general and sleep clinic populations, with closely matched case control series also reporting raised blood pressure in OSA patients. A direct temporal causal association between the onset of obstructive sleep apnoea and raised blood pressure is expected to be confirmed by longitudinal data from the continuing epidemiological population studies. Finally, several studies on the beneficial effects of nasal continuous positive airway pressure in reducing blood pressure in OSA patients have preliminary results in abstract form, with one published in full.

Entities:  

Mesh:

Year:  2002        PMID: 12531119     DOI: 10.1053/smrv.2001.0189

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  19 in total

1.  Randomized controlled trial of variable-pressure versus fixed-pressure continuous positive airway pressure (CPAP) treatment for patients with obstructive sleep apnea/hypopnea syndrome (OSAHS).

Authors:  Marjorie Vennelle; Sandra White; Renata L Riha; Tom W Mackay; Heather M Engleman; Neil J Douglas
Journal:  Sleep       Date:  2010-02       Impact factor: 5.849

2.  Cohort profile: the Western Australian Sleep Health Study.

Authors:  Sutapa Mukherjee; David Hillman; Jessica Lee; Annette Fedson; Laila Simpson; Kim Ward; Gregory Love; Cass Edwards; Bernadett Szegner; Lyle John Palmer
Journal:  Sleep Breath       Date:  2011-02-12       Impact factor: 2.816

3.  A new predictive model for continuous positive airway pressure in the treatment of obstructive sleep apnea.

Authors:  Matthew R Ebben; Mariya Narizhnaya; Ana C Krieger
Journal:  Sleep Breath       Date:  2016-11-22       Impact factor: 2.816

4.  Comparison of the upper airway dynamics of oronasal and nasal masks with positive airway pressure treatment using cine magnetic resonance imaging.

Authors:  Matthew R Ebben; Sara Milrad; Jonathan P Dyke; C Douglas Phillips; Ana C Krieger
Journal:  Sleep Breath       Date:  2015-04-30       Impact factor: 2.816

Review 5.  Therapeutic potential of intermittent hypoxia: a matter of dose.

Authors:  Angela Navarrete-Opazo; Gordon S Mitchell
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-09-17       Impact factor: 3.619

6.  High levels of inflammation and insulin resistance in obstructive sleep apnea patients with hypertension.

Authors:  Xiaoshun Qian; Tong Yin; Tianzhi Li; Chunyan Kang; Ruibiao Guo; Baojun Sun; Changting Liu
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

7.  Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea: a pilot study.

Authors:  Mohammed A Alzoghaibi; Ahmed S O Bahammam
Journal:  Sleep Breath       Date:  2005-09       Impact factor: 2.816

8.  Epworth Sleepiness Scale may be an indicator for blood pressure profile and prevalence of coronary artery disease and cerebrovascular disease in patients with obstructive sleep apnea.

Authors:  Jing Feng; Quan-ying He; Xi-long Zhang; Bao-yuan Chen
Journal:  Sleep Breath       Date:  2011-01-19       Impact factor: 2.816

9.  Determinants of daytime blood pressure in relation to obstructive sleep apnea in men.

Authors:  Jamie C M Lam; Clara S W Yan; Agnes Y K Lai; Sidney Tam; Daniel Y T Fong; Bing Lam; Mary S M Ip
Journal:  Lung       Date:  2009-08-05       Impact factor: 2.584

10.  Alterations in Glucose Disposal in Sleep-disordered Breathing.

Authors:  Naresh M Punjabi; Brock A Beamer
Journal:  Am J Respir Crit Care Med       Date:  2008-11-14       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.